Ojone Ofagbor
Robotic assistance in laparoscopic surgery has significantly advanced minimally invasive surgery (MIS), offering enhanced precision, dexterity, and visualization. The da Vinci surgical system, introduced in 1999, has dominated the market for over 20 years. However, the expiration of some of its patents has allowed new systems to emerge.
Several robotic systems are in use, including the da Vinci Xi and SP, Senhance, Revo-I, Versius, Avatera, and Hinotori. Each system has unique features, such as haptic feedback, open-console designs, and smaller instruments. The da Vinci Xi, for example, is known for its multiquadrant surgery capabilities and port-hopping camera, while the Senhance system offers eye-tracking camera control and haptic feedback.
The introduction of these new systems is expected to increase competition, potentially lowering costs and driving further innovation in robotic surgery. This highlights the importance of competition in promoting technological advancements and improving patient care. There is also the challenge faced by new entrants in the market, such as gaining regulatory approval and surgeon adoption.
Finally, the ongoing evolution of robotic surgical systems and their potential to enhance surgical outcomes and patient care in urology. The future of robotic surgery looks promising, with continuous innovation and the development of new technologies aimed at improving the precision, safety, and accessibility of minimally invasive procedures
Add comment
Comments